Navigation Links
Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
Date:4/21/2009

s TRPP8) was identified through Dendreon's in-house discovery efforts. It is an ion channel that is triggered by cold temperatures and small-molecule agonists and belongs to the melastatin subfamily - one of seven subfamilies of TRP proteins. In normal human tissues, TRPM8 is expressed predominantly in the prostate, a gland in the male reproductive system. It is over-expressed in prostate hyperplasia and multiple types of cancer including prostate cancer, breast cancer, colon cancer and lung cancer. In recent years, it has emerged that TRP channels play a diverse and key role in cell biology and in pathology. Dendreon has synthesized small molecule agonists including D3263 that activate the TRPM8 ion channel and induce cell death.

About Dendreon

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Dendreon also is developing an orally-available small molecule that targets TRPM8 that could be applicable to multiple types of cancer as well as BPH. The Company has its headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit www.dendreon.com.

Except for historical information contained herein, this news release contains forward-looking statements that are subject to risks and uncertainties surrounding the presentation of data to the FDA and approval of product applications by the FDA and risks and uncertainties inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human t
'/>"/>

SOURCE Dendreon Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
3. Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
4. Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia
5. Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery
6. Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October
7. Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial
8. Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial
9. Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
10. Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial
11. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 11, 2014 Patient engagement has become ... organizations are turning to an assortment of marketing ... part of this evolving approach to patient engagement, ... and engage patients throughout their experiences with a ... By mapping the patient journey and employing a ...
(Date:7/11/2014)... 11, 2014  Rock Creek Pharmaceuticals, Inc. (NASDAQ: ... that the Food and Drug Administration ("FDA"), has notified ... RCP,s Investigational New Drug ("IND") application before granting the ... US. Dr. Chris Chapman , RCP,s ... on our IND. When we receive the agency,s official ...
(Date:7/11/2014)... DALLAS , July 11, 2014 ... report "Scintillator Market by Composition of Material, Application ... and others), End Product (Personal Instrument, Hand-Held Instruments, ... Forecast and Analysis to 2013 - 2020", published by MarketsandMarkets, ... a CAGR of 5.62% from 2014 to 2020, ...
Breaking Medicine Technology:New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2Rock Creek Pharmaceuticals Issues Update On US Investigational New Drug Application 2Scintillator Market will be worth $479.16 Million by 2020 2Scintillator Market will be worth $479.16 Million by 2020 3Scintillator Market will be worth $479.16 Million by 2020 4
... , , , ... (Nasdaq: AMGN ) today announced the publication of results from ... at reducing fracture risk in more than 7,800 women with postmenopausal osteoporosis ... deprivation therapy (ADT) leading to bone loss. In both studies, published today ...
... , , , ... BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today that the ... chronically infected with the hepatitis C virus (HCV). The trial, run in ... clemizole monotherapy in the absence of interferon. , , ...
Cached Medicine Technology:Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 2Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 3Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 4Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 5Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 6Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 7Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 8Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 9Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 10Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 11Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial 2Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial 3
(Date:7/11/2014)... Miriam Hospital have found that people with mobility ... of smoking than those without mobility impairments. Additionally, ... attempt quitting than those without mobility impairments, and ... this population. The study and its findings are ... American Journal of Public Health . ...
(Date:7/11/2014)... has found that organic foods and crops have ... including more antioxidants and fewer, less frequent pesticide ... 343 peer-reviewed publications comparing the nutritional quality and ... fruits, vegetables, and grains. The study team applied ... and non-organic foods. , "Science marches on," ...
(Date:7/11/2014)... Delaying surgery to repair damage to the anterior cruciate ligament ... knee -- could increase a young athlete,s risk for further ... 130 patients, aged 8 to 16, who had ACL reconstruction ... weeks after their injury, 37 had surgery six to 12 ... months after their injury. The youngsters who had surgery ...
(Date:7/11/2014)... Prostate cancer patients are more likely to be diagnosed ... sooner if they also have depression, a new study ... American men who were diagnosed with localized prostate cancer ... Nearly 1,900 of the patients had been diagnosed with ... was discovered. "Men with intermediate- or high-risk prostate ...
(Date:7/11/2014)... Ticket Down is a reliable ... Train Amphitheatre in Wheatland, CA. In the Sacramento ... what the Sleep Train Amphitheatre can do for music fans. ... over the course of its existence and can seat 18,500 ... in Wheatland (Sacramento metro area) will host the “That’s My ...
Breaking Medicine News(10 mins):Health News:Miriam Hospital study examines smoking prevalence 2Health News:Major study documents nutritional and food safety benefits of organic farming 2Health News:Major study documents nutritional and food safety benefits of organic farming 3Health News:Delaying Kid's Knee Surgery Could Be a Bad Play, Study Finds 2Health News:Depression May Make It Harder to Beat Prostate Cancer 2Health News:Luke Bryan Tickets Sleep Train Amphitheatre in Wheatland, CA (Sacramento): Ticket Down has Slashed Ticket Prices on Luke Bryan in Wheatland at Sleep Train 2Health News:Luke Bryan Tickets Sleep Train Amphitheatre in Wheatland, CA (Sacramento): Ticket Down has Slashed Ticket Prices on Luke Bryan in Wheatland at Sleep Train 3
... of refugees settled in the makeshift relief camps of ... of Chhattisgarh.// ,UNICEF will specifically look into ... settled in these camps. ,According to ... the organisation's representative in India, met Chhattisgarh chief minister ...
... towards water to chill out. Places such as backyard pool, hot ... very for cautious and always follow the instructions of their parents. ... all the safety measures such as installing the pool fences and ... fail to install the child proof safety measures as it is ...
... gay men who have also been diagnosed as HIV-positive seemed ... status to others//. ,The study, the first of ... HIV-positive men who are often uncertain whether to tell friends, ... that causes AIDS. It was published in the April issue ...
... fees for admittance into various medical courses offered by ... education and research department// of the Punjab government. The ... medical and paramedical courses. ,Representatives of medical ... consultation regarding the actual fees to be fixed for ...
... in which the sinuses become inflamed or infected affecting ... conventional surgery//. But now Acclarent has come up with ... a small balloon in the sinus cavity which clears ... breakthrough that offers hope to many sinusitis sufferers. It ...
... High Court has sought an explanation from medical superintendent ... disclosure of sufficient details after a boy, suffering from ... the hospital in 2001. ,Aggrieved with the ... the hospital to explain its unwillingness to disclose details ...
Cached Medicine News:Health News:Hot Tubs and Spas in the News for Safety Measures 2Health News:Gays Have No Regrets 2Health News:Gays Have No Regrets 3Health News:Provisional Fees For Medical Courses Fixed By Punjab Government 2Health News:Teething Problems of Sinuplasty 2
Standard general retractor system. Fully-adjustable to maintain a low profile in any approach and any patient. Blades can be stacked on top of each other in the operative site....
These retractors are packaged singly ready for sterilization at your facility....
... Pipetman Concept is a revolutionary ... and flexibility in mind, Pipetman Concept ... direct pipette-to-PC connectionthe only one of ... used with Diamond Tips from Gilson, ...
... 3 - Vivid family system designed to ... cardiovascular performance, and offer an even wider ... and the OR. , ,From color flow ... connectivity, the new Vivid 3 offers a ...
Medicine Products: